Annual SG&A
$20.57 M
-$44.47 M-68.38%
31 December 2023
Summary:
Kala Pharmaceuticals annual selling, general & administrative expenses is currently $20.57 million, with the most recent change of -$44.47 million (-68.38%) on 31 December 2023. During the last 3 years, it has fallen by -$60.50 million (-74.63%). KALA annual SG&A is now -80.42% below its all-time high of $105.06 million, reached on 31 December 2021.KALA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.40 M
+$83.00 K+1.92%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly selling, general & administrative expenses is currently $4.40 million, with the most recent change of +$83.00 thousand (+1.92%) on 30 September 2024. Over the past year, it has dropped by -$552.00 thousand (-11.15%). KALA quarterly SG&A is now -84.28% below its all-time high of $27.99 million, reached on 30 June 2021.KALA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.58 B
-$38.96 M-1.53%
30 September 2024
Summary:
Kala Pharmaceuticals TTM selling, general & administrative expenses is currently -$2.58 billion, with the most recent change of -$38.96 million (-1.53%) on 30 September 2024. Over the past year, it has dropped by -$2.60 billion (-11953.80%). KALA TTM SG&A is now -2701.44% below its all-time high of $107.50 million, reached on 30 September 2021.KALA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.4% | -11.2% | -10000.0% |
| 3 y3 years | -74.6% | -82.6% | -2501.1% |
| 5 y5 years | -42.0% | -71.2% | -4080.1% |
KALA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -80.4% | at low | -83.7% | +1.9% | -44.1% | at low |
| 5 y | 5 years | -80.4% | at low | -84.3% | +1.9% | -171.3% | at low |
| alltime | all time | -80.4% | +346.2% | -84.3% | +277.7% | -2701.4% | at low |
Kala Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.40 M(+1.9%) | $18.76 M(-2.9%) |
| June 2024 | - | $4.32 M(-20.4%) | $19.31 M(-3.2%) |
| Mar 2024 | - | $5.42 M(+17.3%) | $19.96 M(-3.0%) |
| Dec 2023 | $20.57 M(-68.4%) | $4.62 M(-6.6%) | $20.57 M(-5.5%) |
| Sept 2023 | - | $4.95 M(-0.2%) | $21.77 M(-17.4%) |
| June 2023 | - | $4.96 M(-17.7%) | $26.37 M(-40.2%) |
| Mar 2023 | - | $6.03 M(+3.4%) | $44.08 M(-32.2%) |
| Dec 2022 | $65.03 M(-38.1%) | $5.83 M(-38.9%) | $65.03 M(-21.9%) |
| Sept 2022 | - | $9.55 M(-57.9%) | $83.23 M(-16.0%) |
| June 2022 | - | $22.67 M(-16.0%) | $99.03 M(-5.1%) |
| Mar 2022 | - | $26.98 M(+12.3%) | $104.34 M(-0.7%) |
| Dec 2021 | $105.06 M(+29.6%) | $24.03 M(-5.2%) | $105.06 M(-2.3%) |
| Sept 2021 | - | $25.35 M(-9.4%) | $107.50 M(+1.4%) |
| June 2021 | - | $27.99 M(+1.0%) | $106.04 M(+13.6%) |
| Mar 2021 | - | $27.70 M(+4.7%) | $93.36 M(+15.2%) |
| Dec 2020 | $81.07 M | $26.47 M(+10.8%) | $81.07 M(+17.3%) |
| Sept 2020 | - | $23.89 M(+56.2%) | $69.09 M(+14.2%) |
| June 2020 | - | $15.30 M(-0.7%) | $60.48 M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $15.41 M(+6.3%) | $62.19 M(-4.3%) |
| Dec 2019 | $65.02 M(+83.5%) | $14.49 M(-5.2%) | $65.02 M(+0.3%) |
| Sept 2019 | - | $15.28 M(-10.2%) | $64.85 M(+11.7%) |
| June 2019 | - | $17.01 M(-6.7%) | $58.04 M(+20.5%) |
| Mar 2019 | - | $18.24 M(+27.3%) | $48.19 M(+36.0%) |
| Dec 2018 | $35.43 M(+226.0%) | $14.33 M(+69.2%) | $35.43 M(+34.4%) |
| Sept 2018 | - | $8.47 M(+18.4%) | $26.36 M(+29.2%) |
| June 2018 | - | $7.15 M(+30.4%) | $20.41 M(+37.7%) |
| Mar 2018 | - | $5.48 M(+4.2%) | $14.82 M(+36.3%) |
| Dec 2017 | $10.87 M(+42.2%) | $5.26 M(+109.1%) | $10.87 M(+25.2%) |
| Sept 2017 | - | $2.52 M(+61.4%) | $8.68 M(+13.4%) |
| June 2017 | - | $1.56 M(+1.8%) | $7.66 M(-4.4%) |
| Mar 2017 | - | $1.53 M(-50.1%) | $8.01 M(+4.8%) |
| Dec 2016 | $7.64 M(+65.8%) | $3.07 M(+106.1%) | $7.64 M(+67.3%) |
| Sept 2016 | - | $1.49 M(-22.0%) | $4.57 M(+48.5%) |
| June 2016 | - | $1.91 M(+64.0%) | $3.08 M(+164.0%) |
| Mar 2016 | - | $1.17 M | $1.17 M |
| Dec 2015 | $4.61 M | - | - |
FAQ
- What is Kala Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual SG&A year-on-year change?
- What is Kala Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly SG&A year-on-year change?
- What is Kala Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM SG&A year-on-year change?
What is Kala Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of KALA is $20.57 M
What is the all time high annual SG&A for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual selling, general & administrative expenses is $105.06 M
What is Kala Pharmaceuticals annual SG&A year-on-year change?
Over the past year, KALA annual selling, general & administrative expenses has changed by -$44.47 M (-68.38%)
What is Kala Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of KALA is $4.40 M
What is the all time high quarterly SG&A for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $27.99 M
What is Kala Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, KALA quarterly selling, general & administrative expenses has changed by -$552.00 K (-11.15%)
What is Kala Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of KALA is -$2.58 B
What is the all time high TTM SG&A for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM selling, general & administrative expenses is $107.50 M
What is Kala Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, KALA TTM selling, general & administrative expenses has changed by -$2.60 B (-11953.80%)